Tedizolid: all 35 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)RecruitingNCT05534750Phase 2
• Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective EndocarditisRecruitingNCT05398679Phase 4
• A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)CompletedNCT03217565Phase 1Results posted
• A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)CompletedNCT03176134Phase 3Results posted
• Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER)CompletedNCT03009045Phase 2Results posted
• A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)CompletedNCT02750761Phase 1Results posted
• Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo MicrodialysisCompletedNCT02620787Phase 1Results posted
• Pharmacokinetics of Tedizolid Phosphate in Cystic FibrosisCompletedNCT02444234Phase 4Results posted
• Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese AdultsCompletedNCT02342418Phase 4Results posted
• Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)CompletedNCT02276482Phase 3Results posted
• Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)CompletedNCT02066402Phase 3Results posted
• Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)CompletedNCT02019420Phase 3Results posted
• Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) InfectionsCompletedNCT01967225Phase 3Results posted
• A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA StudyCompletedNCT01519778Phase 2Results posted
• TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT01421511Phase 3Results posted
• TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.CompletedNCT01170221Phase 3Results posted
• Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure InfectionsCompletedNCT00761215Phase 2Results posted
• A Study to Evaluate Oral Formulations of Tedizolid Phosphate in Healthy Participants (MK-1986-043)CompletedNCT06733688Phase 1
• Tedizolid Prolonged Treatment for Prosthetic Joint InfectionsCompletedNCT03378427Not applicable
• A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004)CompletedNCT02477514Phase 1
• Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male VolunteersCompletedNCT02097043Phase 1
• A Phase 1, Open-Label, 10 Day Safety StudyCompletedNCT01623401Phase 1
• A Phase 1 Crossover Study of Blood Pressure and Heart Rate ResponseCompletedNCT01577459Phase 1
• A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine ChallengeCompletedNCT01539473Phase 1
• Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly SubjectsCompletedNCT01496677Phase 1
• A Thorough QT Study of TR-701free Acid (FA) in Healthy SubjectsCompletedNCT01461460Phase 1
• A Pharmacokinetics and Safety Study in Subjects With Renal ImpairmentCompletedNCT01452828Phase 1
• A PK and Safety Study in Subjects With Hepatic ImpairmentCompletedNCT01431833Phase 1
• Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mgCompletedNCT01271998Phase 1
• Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent PatientsCompletedNCT01156077Phase 1
• Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)CompletedNCT00983255Phase 1
• Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid PhosphateCompletedNCT00876655Phase 1
• Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy AdultsCompletedNCT00671814Phase 1
• Food Effects of Single Oral Dose of 600mg TR-701CompletedNCT00671359Phase 1
• Microdialysis and Pharmacokinetic Study of TR-701CompletedNCT00666601Phase 1

← Tedizolid overview